vs

Side-by-side financial comparison of AMERICAS CARMART INC (CRMT) and Ecovyst Inc. (ECVT). Click either name above to swap in a different company.

AMERICAS CARMART INC is the larger business by last-quarter revenue ($286.3M vs $199.4M, roughly 1.4× Ecovyst Inc.). On growth, Ecovyst Inc. posted the faster year-over-year revenue change (34.0% vs 0.2%). Ecovyst Inc. produced more free cash flow last quarter ($22.9M vs $8.3M). Over the past eight quarters, Ecovyst Inc.'s revenue compounded faster (18.7% CAGR vs 9.1%).

Americas CarMart Inc is a US-based specialty automotive retailer that primarily sells used vehicles and provides tailored in-house financing solutions for customers with limited or poor credit histories. It operates a network of physical dealerships concentrated in the Southern and Midwestern regions of the United States, serving underserved consumer segments in the automotive purchase market.

Ecovyst Inc. is a global sustainable specialty materials provider that develops and manufactures high-performance catalysts and functional additives. Its offerings serve key segments including industrial manufacturing, consumer goods, and environmental protection, helping clients improve operational efficiency and lower carbon emissions across North America, Europe, and Asia-Pacific markets.

CRMT vs ECVT — Head-to-Head

Bigger by revenue
CRMT
CRMT
1.4× larger
CRMT
$286.3M
$199.4M
ECVT
Growing faster (revenue YoY)
ECVT
ECVT
+33.8% gap
ECVT
34.0%
0.2%
CRMT
More free cash flow
ECVT
ECVT
$14.7M more FCF
ECVT
$22.9M
$8.3M
CRMT
Faster 2-yr revenue CAGR
ECVT
ECVT
Annualised
ECVT
18.7%
9.1%
CRMT

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
CRMT
CRMT
ECVT
ECVT
Revenue
$286.3M
$199.4M
Net Profit
$-22.5M
Gross Margin
37.5%
23.4%
Operating Margin
-9.6%
10.9%
Net Margin
-7.8%
Revenue YoY
0.2%
34.0%
Net Profit YoY
-540.7%
EPS (diluted)
$-2.71
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRMT
CRMT
ECVT
ECVT
Q4 25
$286.3M
$199.4M
Q3 25
$276.2M
$204.9M
Q2 25
$309.7M
$176.1M
Q1 25
$263.5M
$143.1M
Q4 24
$285.8M
$148.9M
Q3 24
$287.2M
$153.9M
Q2 24
$309.7M
$154.0M
Q1 24
$240.4M
$141.6M
Net Profit
CRMT
CRMT
ECVT
ECVT
Q4 25
$-22.5M
Q3 25
$-5.7M
$-79.3M
Q2 25
$10.6M
$6.0M
Q1 25
$3.2M
$-3.6M
Q4 24
$5.1M
Q3 24
$-964.0K
$14.3M
Q2 24
$426.0K
$8.3M
Q1 24
$-8.5M
$1.2M
Gross Margin
CRMT
CRMT
ECVT
ECVT
Q4 25
37.5%
23.4%
Q3 25
36.6%
25.4%
Q2 25
36.4%
22.8%
Q1 25
35.7%
13.3%
Q4 24
39.4%
28.9%
Q3 24
35.0%
29.3%
Q2 24
35.1%
27.3%
Q1 24
34.2%
23.5%
Operating Margin
CRMT
CRMT
ECVT
ECVT
Q4 25
-9.6%
10.9%
Q3 25
-2.7%
13.8%
Q2 25
4.0%
9.0%
Q1 25
1.7%
-0.7%
Q4 24
2.5%
15.1%
Q3 24
-0.4%
17.9%
Q2 24
14.1%
Q1 24
-4.3%
9.5%
Net Margin
CRMT
CRMT
ECVT
ECVT
Q4 25
-7.8%
Q3 25
-2.1%
-38.7%
Q2 25
3.4%
3.4%
Q1 25
1.2%
-2.5%
Q4 24
1.8%
Q3 24
-0.3%
9.3%
Q2 24
0.1%
5.4%
Q1 24
-3.6%
0.9%
EPS (diluted)
CRMT
CRMT
ECVT
ECVT
Q4 25
$-2.71
$0.06
Q3 25
$-0.69
$-0.69
Q2 25
$1.50
$0.05
Q1 25
$0.37
$-0.03
Q4 24
$0.61
$-0.26
Q3 24
$-0.15
$0.12
Q2 24
$0.09
$0.07
Q1 24
$-1.34
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRMT
CRMT
ECVT
ECVT
Cash + ST InvestmentsLiquidity on hand
$122.4M
$197.2M
Total DebtLower is stronger
$392.6M
Stockholders' EquityBook value
$555.0M
$603.4M
Total Assets
$1.7B
$1.3B
Debt / EquityLower = less leverage
0.65×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRMT
CRMT
ECVT
ECVT
Q4 25
$122.4M
$197.2M
Q3 25
$9.7M
$82.0M
Q2 25
$9.8M
$69.6M
Q1 25
$8.5M
$127.5M
Q4 24
$8.0M
$131.4M
Q3 24
$4.7M
$123.5M
Q2 24
$5.5M
$83.3M
Q1 24
$4.2M
$103.1M
Total Debt
CRMT
CRMT
ECVT
ECVT
Q4 25
$392.6M
Q3 25
$854.8M
Q2 25
$856.6M
Q1 25
$859.0M
Q4 24
$860.8M
Q3 24
$862.7M
Q2 24
$862.4M
Q1 24
$866.2M
Stockholders' Equity
CRMT
CRMT
ECVT
ECVT
Q4 25
$555.0M
$603.4M
Q3 25
$564.8M
$607.9M
Q2 25
$569.4M
$692.4M
Q1 25
$557.8M
$698.7M
Q4 24
$553.6M
$700.5M
Q3 24
$471.1M
$729.4M
Q2 24
$470.6M
$717.3M
Q1 24
$468.9M
$711.4M
Total Assets
CRMT
CRMT
ECVT
ECVT
Q4 25
$1.7B
$1.3B
Q3 25
$1.6B
$1.7B
Q2 25
$1.6B
$1.8B
Q1 25
$1.6B
$1.8B
Q4 24
$1.6B
$1.8B
Q3 24
$1.5B
$1.8B
Q2 24
$1.5B
$1.8B
Q1 24
$1.5B
$1.8B
Debt / Equity
CRMT
CRMT
ECVT
ECVT
Q4 25
0.65×
Q3 25
1.41×
Q2 25
1.24×
Q1 25
1.23×
Q4 24
1.23×
Q3 24
1.18×
Q2 24
1.20×
Q1 24
1.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRMT
CRMT
ECVT
ECVT
Operating Cash FlowLast quarter
$9.1M
$41.8M
Free Cash FlowOCF − Capex
$8.3M
$22.9M
FCF MarginFCF / Revenue
2.9%
11.5%
Capex IntensityCapex / Revenue
0.3%
9.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-11.2M
$69.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRMT
CRMT
ECVT
ECVT
Q4 25
$9.1M
$41.8M
Q3 25
$-5.9M
$55.3M
Q2 25
$19.2M
$33.0M
Q1 25
$-30.8M
$10.3M
Q4 24
$-22.2M
$43.5M
Q3 24
$-15.0M
$59.9M
Q2 24
$-10.7M
$10.0M
Q1 24
$13.0M
$36.5M
Free Cash Flow
CRMT
CRMT
ECVT
ECVT
Q4 25
$8.3M
$22.9M
Q3 25
$-6.4M
$53.2M
Q2 25
$18.4M
$7.8M
Q1 25
$-31.5M
$-14.0M
Q4 24
$-23.6M
$30.9M
Q3 24
$-16.0M
$53.6M
Q2 24
$-12.0M
$-9.3M
Q1 24
$10.2M
$19.1M
FCF Margin
CRMT
CRMT
ECVT
ECVT
Q4 25
2.9%
11.5%
Q3 25
-2.3%
26.0%
Q2 25
5.9%
4.4%
Q1 25
-12.0%
-9.8%
Q4 24
-8.3%
20.7%
Q3 24
-5.6%
34.9%
Q2 24
-3.9%
-6.1%
Q1 24
4.3%
13.5%
Capex Intensity
CRMT
CRMT
ECVT
ECVT
Q4 25
0.3%
9.4%
Q3 25
0.2%
1.0%
Q2 25
0.3%
14.4%
Q1 25
0.3%
16.9%
Q4 24
0.5%
8.5%
Q3 24
0.3%
4.1%
Q2 24
0.4%
12.5%
Q1 24
1.1%
12.3%
Cash Conversion
CRMT
CRMT
ECVT
ECVT
Q4 25
Q3 25
Q2 25
1.81×
5.52×
Q1 25
-9.73×
Q4 24
-4.36×
Q3 24
4.21×
Q2 24
-25.18×
1.20×
Q1 24
29.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRMT
CRMT

Sales Used Autos$241.4M84%
Service Contract Sales$23.6M8%
Wholesales Third Party$12.6M4%
Payment Protection Plan Revenue$8.7M3%

ECVT
ECVT

Industrial Mining Automotive$101.3M51%
Regeneration And Treatment Services$90.0M45%
Other$8.1M4%

Related Comparisons